Our guide to new NICE guidance on ankylosing spondylitis, a chronic condition affecting 200,000 people in the UK.
About 200,000 people have ankylosing spondylitis in the UK, with approximately 2,300 new diagnoses each year in England and Wales. A form of arthritis, the chronic condition causes inflammation in the spine and other areas of the body. It is about three times more common in men than in women.
New draft guidance from the National Institute of Health and Care Excellence (NICE) means thousands of people with ankylosing spondylitis will soon have access to an innovative new drug. Secukinumab, which helps patients by reducing inflammation and pain and improving mobility, is the first in a new class of drug to...
Want to read more?
Unlock full access to RCNi Plus today
Save over 50% on your first three months:
- Customisable clinical dashboard featuring 200+ topics
- Unlimited online access to all 10 RCNi Journals including Nursing Standard
- RCNi Learning featuring 180+ RCN accredited learning modules
- NMC-compliant RCNi Portfolio to build evidence for revalidation
- Personalised newsletters tailored to your interests